Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7537 - 7544 of 12085 results
The Use of Experts in International Arbitration: Tribunal-Appointed Experts
December 14, 2016| Blog| Viewpoint
The Use of Experts in International Arbitration: Preparing the Expert Witness to Give Oral Testimony
December 14, 2016| Blog| Viewpoint
#MLWashingtonCyberWatch: White House Releases Cybersecurity Report Aimed at New Administration
December 14, 2016| Blog| Viewpoint
The Rise of Shared Work Spaces: Tips For The Unwary
December 14, 2016| News
UC president: The biggest job in SW Ohio?
December 14, 2016| News
Treasury/IRS Provide Early Holiday Present: Final “Issue Price” Regulations Released
December 13, 2016| Blog| Viewpoint
Obama Administration Announces New Financing and Innovation Actions for Renewable Energy
December 12, 2016| Blog| Viewpoint
At Long Last, OIG Issues Final Rule for Beneficiary Inducement Safe Harbors
December 12, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|